Joanne Curley's Net Worth
$2.15 Million
Who is Joanne Curley?
Joanne Curley has an estimated net worth of $2.15 Million. This is based on reported shares across multiple companies, which include Vera Therapeutics, Inc., and Vistagen Therapeutics, Inc..
SEC CIK
Joanne Curley's CIK is 0001857670
Past Insider Trading and Trends
2022 was Joanne Curley's most active year for acquiring shares with 41 total transactions. Joanne Curley's most active month to acquire stocks was the month of July. 2022 was Joanne Curley's most active year for disposing of shares, totalling 73 transactions. Joanne Curley's most active month to dispose stocks was the month of June. 2022 saw Joanne Curley paying a total of $668,650.75 for 255,770 shares, this is the most they've acquired in one year. In 2022 Joanne Curley cashed out on 191,485 shares for a total of $1,791,424.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.25
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.24% | -1.49K |
$16.66 | -$24,817.14 | 26.96K |
Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
$11.19 | -$36,708.21 | 26.82K |
Scheduled
|
Dec 16
| ||
Form 4
|
—
|
0
|
$14.51 | -$148,140.08 | 26.82K |
Scheduled
|
Dec 12 - Dec 13
| ||
Form 4
| -1.81% | -494.00 |
$16.47 | -$8,136.18 | 26.82K |
Scheduled
|
Dec 7
| ||
Form 4
|
—
|
0
|
$9.95 | -$38,853.23 | 27.32K |
Scheduled
|
Nov 17
| ||
Form 4
| -1.78% | -494.00 |
$16.54 | -$8,170.76 | 27.32K |
Scheduled
|
Nov 9
| ||
Form 4
|
—
|
0
|
$13.87 | -$95,157.35 | 27.81K |
Scheduled
|
Oct 18
| ||
Form 4
| -3.43% | -988.00 |
$21.64 | -$21,380.32 | 27.81K |
Scheduled
|
Oct 5
| ||
Form 4
|
—
|
0
|
$15.19 | -$186,211.22 | 28.8K |
Scheduled
|
Sep 20 - Sep 21
| ||
Form 4
| -3.32% | -988.00 |
$18.63 | -$18,406.44 | 28.8K |
Scheduled
|
Sep 7
| ||
Form 4
| +72.32% | 12.5K |
$13.75 | -$91,959.20 | 29.79K |
Scheduled
|
Aug 19 - Aug 22
| ||
Form 4
| -5.41% | -988.00 |
$16.81 | -$16,608.28 | 17.29K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$10.27 | -$131,384.47 | 18.27K |
Scheduled
|
Jul 19
| ||
Form 4
| -13.08% | -2.75K |
$9.02 | -$119,457.44 | 18.27K |
Scheduled
|
Jul 14
| ||
Form 4
| -11.25% | -2.67K |
$9.84 | -$113,052.08 | 21.02K |
Scheduled
|
Jul 7
| ||
Form 4
| -1.28% | -306.00 |
$10.69 | -$15,302.05 | 23.69K |
Scheduled
|
Jun 22
| ||
Form 4
| -4.76% | -1.20K |
$9.47 | -$70,309.49 | 23.99K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$10.80 | -$3,537.08 | 25.19K |
Scheduled
|
May 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vistagen Therapeutics, Inc. (VTGN) Snapshot price: $4.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||